FDA approves Moderna’s next-gen Covid vaccine, with limits on most healthy people
FDA approves Moderna’s mNEXSPIKE Covid vaccine for ages 12+ with risk factors and all 65+. CEO Stéphane Bancel welcomes approval of shot that uses lower dose than Spikevax.